Myeloid aCDase deficiency protects against tumor occurrence in colitis-associated cancer and limits the expansion of neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment (Venable et al., 1994; Espaillat et al., 2018). The gene discussed is ASAH1; the disease is neoplasm.